Development and Validation of CXCR4 Nomogram-Based Immune Infiltration/Tumor Inflammation in Primary Glioblastoma

Development and Validation of CXCR4 Nomogram-Based Immune Infiltration/Tumor Inflammation in Primary Glioblastoma

Glioblastoma (GBM) is a highly malignant and aggressive tumor with poor prognosis. Therefore, the discovery of new prognostic molecular markers is of great significance for clinical prognosis. The CXC chemokine receptor (CXCR) members play a key regulatory role in many cancers. In this study, we exp...

Full description

Bibliographic Details
Main Authors:	Guannan Jiang, Zong-Qing Zheng, Jie Zhang, Zhichao Tian, Xiang Li, Zhengquan Yu, Zhong Wang, Wanchun You, Gang Chen
Format:	Article
Language:	English
Published:	MDPI AG 2023-08-01
Series:	Brain Sciences
Subjects:	glioblastoma C-X-C motif chemokine receptor 4 nomogram inflammation immune-cell infiltration
Online Access:	https://www.mdpi.com/2076-3425/13/8/1152

Similar Items

Development and validation of an immune infiltration/tumor proliferation-related Notch3 nomogram for predicting survival in patients with primary glioblastoma
by: Zong-Qing Zheng, et al.
Published: (2023-05-01)

Effects of CXCR2 on invasion, migration and apoptosis of gastric cancer cells
by: LU Weihui, LIU Wei, WANG Cong, WANG Zhenglin
Published: (2021-09-01)

Predictive value of CCL2 in the prognosis and immunotherapy response of glioblastoma multiforme
by: Longfei Deng, et al.
Published: (2023-12-01)

Inhibition of <i>Cxcr4</i> Disrupts Mouse Embryonic Palatal Mesenchymal Cell Migration and Induces Cleft Palate Occurrence
by: Xiaoyu Zheng, et al.
Published: (2023-08-01)

Insights into Gene Regulation under Temozolomide-Promoted Cellular Dormancy and Its Connection to Stemness in Human Glioblastoma
by: Carolin Kubelt, et al.
Published: (2023-05-01)

Serum Levels of CXCL13 Are an Independent Predictor of Survival Following Resection of Biliary Tract Cancer
by: Sven H. Loosen, et al.
Published: (2022-08-01)

Correlation of serum and local CXCL13 levels with disease severity in patients with non-traumatic osteonecrosis of femoral head
by: Yong-Heng Zhao, et al.
Published: (2024-03-01)

Serum CXCL5 Detects Early Hepatocellular Carcinoma and Indicates Tumor Progression
by: Alena Laschtowitz, et al.
Published: (2023-03-01)

Serum CXCL10 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced BCLC stage C hepatocellular carcinoma: A multicenter analysis
by: Takanori Suzuki, et al.
Published: (2024-01-01)

Comprehensive bioinformatic analysis constructs a CXCL model for predicting survival and immunotherapy effectiveness in ovarian cancer
by: Shuang Li, et al.
Published: (2023-03-01)

DOCK2 and phosphoinositide-3 kinase δ mediate two complementary signaling pathways for CXCR5-dependent B cell migration
by: Stefanie Wissmann, et al.
Published: (2022-10-01)

C-X3-C motif chemokine ligand 1/receptor 1 regulates the M1 polarization and chemotaxis of macrophages after hypoxia/reoxygenation injury
by: Shuiming Guo, et al.
Published: (2021-12-01)

On the Role of Paraoxonase-1 and Chemokine Ligand 2 (C-C motif) in Metabolic Alterations Linked to Inflammation and Disease. A 2021 Update
by: Jordi Camps, et al.
Published: (2021-07-01)

CXCR4 Antagonists as Stem Cell Mobilizers and Therapy Sensitizers for Acute Myeloid Leukemia and Glioblastoma?
by: Vashendriya V.V. Hira, et al.
Published: (2020-02-01)

Peripheral CCL2 induces inflammatory pain via regulation of Ih currents in small diameter DRG neurons
by: Lamei Li, et al.
Published: (2023-10-01)

KIF2C is a prognostic biomarker associated with immune cell infiltration in breast cancer
by: Shanshan Liu, et al.
Published: (2023-04-01)

Prognostic analysis and nomogram construction for older patients with IDH-wild-type glioblastoma
by: Wenjun Cao, et al.
Published: (2023-07-01)

CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study
by: Chunhong Li, et al.
Published: (2022-09-01)

CXCL17 Attenuates Diesel Exhaust Emissions Exposure-Induced Lung Damage by Regulating Macrophage Function
by: Yize Yin, et al.
Published: (2023-07-01)

IL-10 Promotes CXCL13 Expression in Macrophages Following Foot-and-Mouth Disease Virus Infection
by: Zijing Guo, et al.
Published: (2023-03-01)

Comparison of the Response to the CXCR4 Antagonist AMD3100 during the Development of Retinal Organoids Derived from ES Cells and Zebrafish Retina
by: Yihui Wu, et al.
Published: (2022-06-01)

Inflammatory Biomarker Profiles in Very Preterm Infants within the Context of Preeclampsia, Chorioamnionitis, and Clinically Diagnosed Postnatal Infection
by: Jordan T. Ewald, et al.
Published: (2023-08-01)

Chemokine (C–C motif) receptor 2 is associated with the pathological grade and inflammatory response in IgAN children
by: Yanjie Shen, et al.
Published: (2022-06-01)

Efficacy of Rectal Systemic Administration of Mesenchymal Stem Cells to Injury Sites via the CXCL12/CXCR4 Axis to Promote Regeneration in a Rabbit Skeletal Muscle Injury Model
by: Toru Ichiseki, et al.
Published: (2023-06-01)

Immune cell infiltration and drug response in glioblastoma multiforme: insights from oxidative stress-related genes
by: Kan Wang, et al.
Published: (2024-04-01)

Incorporating circulating cytokines into the idiopathic inflammatory myopathy subclassification toolkit
by: Boel De Paepe
Published: (2023-03-01)

High expression of ARPC1B correlates with immune infiltration and poor outcomes in glioblastoma
by: Chuangxin Liao, et al.
Published: (2024-03-01)

The CXCL2/IL8/CXCR2 Pathway Is Relevant for Brain Tumor Malignancy and Endothelial Cell Function
by: Ruth M. Urbantat, et al.
Published: (2021-03-01)

Reduction in mRNA Expression of the Neutrophil Chemoattract Factor CXCL1 in <i>Pseudomonas aeruginosa</i> Treated Barth Syndrome B Lymphoblasts
by: Hana M. Zegallai, et al.
Published: (2023-05-01)

CXCR3 CHEMOKINE RECEPTOR EXPRESSION ON PERIPHERAL BLOOD B-CELL SUBSETS IN PATIENTS WITH CHRONIC HEPATITIS C
by: N. A. Arsentieva, et al.
Published: (2014-07-01)

CXCL13 in Cancer and Other Diseases: Biological Functions, Clinical Significance, and Therapeutic Opportunities
by: San-Hui Gao, et al.
Published: (2021-11-01)

The Role of Cytokines and Chemokines in Shaping the Immune Microenvironment of Glioblastoma: Implications for Immunotherapy
by: Erica C. F. Yeo, et al.
Published: (2021-03-01)

Immunohistochemical Characterization of Immune Infiltrate in Tumor Microenvironment of Glioblastoma
by: Hassan Rahimi Koshkaki, et al.
Published: (2020-09-01)

CXCL9 expression in breast cancer and its correlation with the characteristics of tumor immunoinfiltration
by: DU Shaoqian, et al.
Published: (2023-07-01)

Discovery of Exosomes From Tick Saliva and Salivary Glands Reveals Therapeutic Roles for CXCL12 and IL-8 in Wound Healing at the Tick–Human Skin Interface
by: Wenshuo Zhou, et al.
Published: (2020-07-01)

Multi-parameter MRI based radiomics nomogram for predicting telomerase reverse transcriptase promoter mutation and prognosis in glioblastoma
by: Ling Chen, et al.
Published: (2023-09-01)

Ferroptosis-related Recurrence Risk Model Predicts Clinical Outcomes and Immune Infiltration in Glioblastoma
by: LIAO Yongzhen, et al.
Published: (2023-03-01)

Exosome-Transmitted miR-128 Targets CCL18 to Inhibit the Proliferation and Metastasis of Urothelial Carcinoma
by: Donghao Shang, et al.
Published: (2022-01-01)

Targeting copper death genotyping associated gene RARRES2 suppresses glioblastoma progression and macrophages infiltration
by: Tao Yan, et al.
Published: (2023-05-01)

Screening seven hub genes associated with prognosis and immune infiltration in glioblastoma
by: Yesen Zhang, et al.
Published: (2022-08-01)